There is a rapid increase in chronic diseases that are closely associated with human genes. Such diseases in the line include arthritis, cancer, heart attack, stroke, and some other relative illnesses. This wide range of diseases is expecting to fuel growth in the global gene panel market in the upcoming years.
The market for gene panels is expected to rise on the back of increased cancer patients. In 2018, the International Agency for Research on Cancer (IRAC) has come up with some facts. The research report has anticipated that the count of new cancer patients may rise by 2040. It is estimated to reach more than 27.5 million. The key factors for this increase include reduced physical activities, smoking, and an unhealthy lifestyle. So for the diagnosis and treatment of cancer, the services provided by the gene panel market become evident, and it further boosts demand in the industry.
Download a Brochure Of The Latest Research Report
In the same year, the World Health Organization has also provided statistics about strokes patients. In the U.S., more than 795,000 people have strokes every year. Such a massive count is expected to further fuel opportunities in the gene panel market. As gene panels are used as a clinical diagnostic tool, so it may bolster future avenues in the industry.
About TMR Research:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
